Your Notifications
All done, no notifications

Rhabdomyosarcoma (RMS) Treatment Cost in Jordan

USD 10000 - USD 25000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

5
Days in Hospital
2-6 hrs*
Procedure Time
70 - 80%
Success Rate
Get Free Treatment Plan Connect with an Expert
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 10000 - USD 25000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator
International Quality. Affordable Care.

How Much Does Rhabdomyosarcoma (RMS) Treatment Cost in Jordan?

Depending on tumour type, stage, location, and the required combination of therapies, the cost of Rhabdomyosarcoma (RMS) treatment in Jordan typically ranges from USD 10000 - USD 25000. Factors such as disease complexity, the duration and intensity of chemotherapy, the use of advanced radiation techniques, and the expertise of paediatric or adult sarcoma specialists can significantly influence overall cost.

Additional expenses may include diagnostic biopsies, histopathology and molecular testing, imaging studies (MRI, CT, PET scans), chemotherapy drugs and supportive medications, radiation therapy planning and sessions, surgical hospitalisation charges, and post-treatment rehabilitation. In many cases, long-term follow-up, including surveillance imaging, blood tests, and management of treatment-related side effects, may be required, which can further increase the total treatment cost.

Factors Influencing the Cost of Rhabdomyosarcoma (RMS) Treatment

  • Type of Treatment Plan: Costs vary depending on whether the patient requires surgery, chemotherapy, radiation therapy, or a multimodal treatment approach combining two or more therapies.
  • Tumour Type, Stage, and Location: Advanced-stage disease, unfavourable tumour locations, or metastatic RMS often require more intensive and prolonged treatment, increasing overall costs.
  • Hospital or Oncology Centre Standards: Specialised cancer centres with paediatric or adult sarcoma units, advanced radiation technology, and comprehensive oncology support services may have higher treatment and facility charges.
  • Specialist’s Expertise: Paediatric oncologists, surgical oncologists, radiation oncologists, and sarcoma specialists with extensive experience in RMS management may command higher professional fees.
  • Pre-Treatment Evaluations: Diagnostic biopsies, histopathology, immunohistochemistry, molecular testing, and imaging studies (MRI, CT, PET scans) contribute significantly to initial evaluation costs.
  • Use of Advanced Technology: Modern radiation techniques, image-guided surgery, and targeted or risk-adapted chemotherapy protocols can substantially increase treatment expenses.
  • Treatment Duration and Intensity: Prolonged chemotherapy cycles, multiple radiation sessions, or staged surgical procedures add to cumulative treatment costs.
  • Post-Treatment Monitoring and Follow-Up: Long-term follow-up including imaging, blood tests, surveillance scans, rehabilitation, and management of treatment-related side effects, contributes to overall expenditure.

What's included in your Rhabdomyosarcoma (RMS) Treatment quote?

Pediatric oncology consultation
Initial evaluation, diagnosis review, and personalised treatment planning
Pediatric Sarcoma Specialists
Blood tests, biopsy review, MRI/CT/PET-CT, and staging investigations
Hospital stay + ICU as needed
Inpatient care, nursing, symptom management, and supportive treatment
Hospital stay monitoring
Imaging, laboratory tests, and oncology consultations to monitor recovery
Visa & medical-visa invite letter
Airport pickup & transfers
Get Itemized Quote FREE

Cost of Rhabdomyosarcoma (RMS) Treatment in Major Cities of Jordan

City Cost (USD)
Amman $10,000 – $25,000 Explore More

Rhabdomyosarcoma Rms Treatment - Jordan Vs the World

India
$5k - $0
United Arab Emirates
$5k - $0
Vietnam
$8k - $20k
Turkey
$18k - $40k
Malaysia
$22k - $45k
Thailand
$22k - $50k
Saudi Arabia
$25k - $55k
South Korea
$30k - $70k
Spain
$30k - $80k
United Kingdom
$30k - $65k
Israel
$50k - $90k
Singapore
$75k - $150k

Find the Right Destination for Your Rhabdomyosarcoma (RMS) Treatment Journey

Jordan
$10,000 – $25,000
JCI-accredited hospitals - Popular Middle East hub - Arabic & English support - Easy regional access
Singapore
$75,000 – $150,000
World-renowned hospitals - Exceptional quality standards - Highly efficient healthcare - English-speaking environment
Switzerland
$50,000 – $100,000
Premium private hospitals - Exceptional quality standards - Personalized patient care - Multilingual healthcare services
Israel
$50,000 – $90,000
Globally recognized medical centers - Advanced clinical research - English-speaking specialists - High international standards
Dr. Vishwas Kaushik
Author

Dr. Vishwas Kaushik

MBBS, MD

7 Years of Experience

Last Reviewed - June 2026

Dr. Vishwas Kaushik is a qualified medical professional holding an MBBS from the prestigious Belgorod State University, Russia, with a strong foundation in clinical medicine and healthcare practice. His comprehensive medical training has equipped him with a profound understanding of evidence-based clinical practices, patient-centered care, and the evolving landscape of modern medicine. With a keen interest in medical research and scientific communication, he consistently translates complex clinical concepts into clear, accurate, and accessible content for diverse audiences. His work reflects a deep commitment to advancing medical knowledge, delivering impactful healthcare insights, and bridging the gap between clinical expertise and accessible medical communication.
View More
Dr Prateek Varshney
Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

Connect with an Expert Request a Free Consultation
15 min
Average response time
Serving Patients Worldwide in Multiple Languages.

Commonly affecting children and young adults, rhabdomyosarcoma (RMS) is an uncommon and aggressive form of soft tissue cancer that arises in skeletal muscle cells. Treatment for rhabdomyosarcoma (RMS) includes radiation therapy to stop recurrence, chemotherapy to reduce or eradicate cancer cells, and surgery to remove the tumor. In certain situations, immunotherapy or targeted therapy may be employed. Rehabilitation and pain management are supportive care that enhances a patient's quality of life.

Explore Hospitals ( 1 )

Amman, Jordan

243+ Beds · 293+ Procedures
JCI

Get Your Rhabdomyosarcoma (RMS) Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Connect with an Expert Book 15-min call
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Watch Story
Patient Testimonial: Mrs Henshaw from Nigeria underwent Cervical Cancer Treatment in India
Mrs. Affiong Uko Henshaw
Mrs Henshaw from Nigeria underwent Cervical Cancer Treatment in India

This was the case with a 60-year-old cervical cancer patient from Nigeria, Mrs. Affiong Uko Henshaw. She was diagnosed with…

Watch Story

Frequently Asked Questions

Rhabdomyosarcoma treatment is advised when a patient:
  • Is diagnosed with embryonal, alveolar, or pleomorphic rhabdomyosarcoma
  • Has a rapidly growing soft-tissue mass, often painful or causing functional impairment
  • Shows tumour spread to nearby tissues, lymph nodes, or distant organs
  • Experiences symptoms related to tumour location such as breathing difficulty, urinary obstruction, or vision problems
  • Has recurrent or progressive disease after initial therapy
    • Eligibility for treatment depends on tumour type, size, location, stage, patient age, overall health, and risk classification (low, intermediate, or high risk).

    Pre-Treatment:
  • Comprehensive oncological evaluation
  • Biopsy and histopathological confirmation
  • Immunohistochemistry and molecular testing
  • Imaging studies (MRI, CT scan, PET scan) to determine tumour extent
  • Bone marrow examination if metastasis is suspected
  • Assessment of organ function and treatment fitness
    • Treatment Approaches:Multimodal Therapy (Standard of Care):Surgery:
  • Tumour removal when anatomically feasible
  • Limb-sparing or organ-preserving techniques whenever possible
    • Chemotherapy:
  • Multi-agent chemotherapy to target microscopic and systemic disease
  • Given before surgery (neoadjuvant) or after surgery (adjuvant)
    • Radiation Therapy:
  • Used when complete surgical removal is not possible
  • Advanced techniques such as IMRT or proton therapy to minimise damage to healthy tissue
    • Duration:
  • Chemotherapy and radiation may continue for several months
  • Treatment duration varies based on risk category and response

    • Potential risks depend on the treatment modality and may include:
  • Chemotherapy-related side effects (nausea, fatigue, hair loss, infections)
  • Radiation-related tissue damage or growth disturbances (in children)
  • Surgical risks such as bleeding, infection, or functional impairment
  • Long-term effects, including fertility issues or organ dysfunction
  • Close monitoring helps reduce complications and improve long-term outcomes.

    • One of the leading hospitals in Jordan is:Arab Medical Center, Amman
  • Experienced paediatric and adult oncologists
  • Advanced imaging and radiation therapy facilities
  • Multidisciplinary sarcoma tumour boards
  • Comprehensive supportive care and long-term follow-up programs

  • Hospital stay: Varies based on surgery and chemotherapy cycles
  • Chemotherapy: Administered in cycles over several months
  • Radiation therapy: Typically delivered over 4-6 weeks
  • Functional recovery: Gradual, depending on tumour location and treatment intensity
    • Long-term follow-up is essential to monitor recurrence, growth, and late effects of therapy.

    Additional expenses may include:
  • Diagnostic biopsies and molecular testing
  • Imaging studies and staging scans
  • Chemotherapy drugs and supportive medications
  • Radiation therapy planning and sessions
  • Rehabilitation, physiotherapy, or psychological support
  • Follow-up visits and long-term surveillance

    • Amman is the preferred destination due to:
  • Availability of specialised paediatric and adult oncology centres
  • Advanced sarcoma treatment infrastructure
  • Multidisciplinary cancer care teams
  • Access to long-term survivorship and follow-up care

  • Experienced oncologists specialising in rare soft-tissue sarcomas
  • Modern chemotherapy, surgical, and radiation technologies
  • Patient-centred, multidisciplinary cancer care
  • Cost-effective treatment compared to many Western countries
  • Strong international patient support and care coordination

  • High survival rates for low-risk and early-stage RMS
  • Improved disease control with risk-adapted multimodal therapy
  • Better long-term outcomes with early diagnosis and complete treatment
  • Quality of life improves with comprehensive rehabilitation and follow-up

    • Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan